Jin Medical International Ltd. (ZJYL)

Jin Medical International Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	22.83	23.5	19.82	19.19	20.76	16.19
Revenue Growth (YoY)	13.42%	18.57%	3.29%	-7.58%	28.22%	-20.49%
Cost of Revenue	14.48	13.89	12.86	12.83	14.18	10.7
Gross Profit	8.35	9.61	6.96	6.36	6.59	5.5
Selling, General & Admin	4.67	4.37	2.37	2.18	2.16	1.88
Research & Development	1.55	1.5	1.54	1.89	1.57	1.26
Other Operating Expenses	0.18	0.11	0.18	0.16	0.23	-
Operating Expenses	6.39	5.97	4.1	4.23	3.95	3.14
Operating Income	1.96	3.64	2.87	2.13	2.63	2.35
Interest Expense	-	-	-	-	-0.01	-0.11
Interest & Investment Income	0.09	0.47	0.18	0.18	-	-
Currency Exchange Gain (Loss)	0.03	-0.03	-0.05	0.19	0.06	-0.01
Other Non Operating Income (Expenses)	0.13	0.11	0.22	0.24	0.19	0.12
Pretax Income	2.2	4.18	3.22	2.74	2.88	2.35
Income Tax Expense	0.47	0.76	0.34	0.04	0.25	0.15
Earnings From Continuing Operations	1.72	3.42	2.88	2.71	2.63	2.21
Minority Interest in Earnings	0.07	0.26	-	-	-	-
Net Income	1.79	3.68	2.88	2.71	2.63	2.21
Net Income to Common	1.79	3.68	2.88	2.71	2.63	2.21
Net Income Growth	-38.31%	27.71%	6.34%	2.84%	19.30%	-39.52%
Shares Outstanding (Basic)	157	156	145	135	135	400
Shares Outstanding (Diluted)	157	156	145	135	135	400
Shares Change (YoY)	0.53%	7.81%	7.51%	-	-66.25%	-
EPS (Basic)	0.01	0.02	0.02	0.02	0.02	0.01
EPS (Diluted)	0.01	0.02	0.02	0.02	0.02	0.01
EPS Growth	-38.63%	18.46%	-1.08%	2.84%	253.54%	-39.53%
Free Cash Flow	-0.81	-1.35	2.99	1.54	5.8	2.36
Free Cash Flow Per Share	-0.01	-0.01	0.02	0.01	0.04	0.01
Gross Margin	36.56%	40.89%	35.14%	33.13%	31.72%	33.95%
Operating Margin	8.57%	15.48%	14.46%	11.10%	12.67%	14.54%
Profit Margin	7.85%	15.64%	14.52%	14.10%	12.67%	13.62%
Free Cash Flow Margin	-3.54%	-5.75%	15.10%	8.03%	27.93%	14.58%
EBITDA	2.2	3.88	3.09	2.49	2.98	2.68
EBITDA Margin	9.66%	16.50%	15.60%	12.99%	14.34%	16.58%
D&A For EBITDA	0.25	0.24	0.23	0.36	0.35	0.33
EBIT	1.96	3.64	2.87	2.13	2.63	2.35
EBIT Margin	8.57%	15.48%	14.46%	11.10%	12.67%	14.54%
Effective Tax Rate	21.58%	18.26%	10.67%	1.32%	8.63%	6.25%
Revenue as Reported	22.83	23.5	19.82	19.19	20.76	16.19

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q